Quantum Surgical

Quantum Surgical is a healthcare technology startup that specializes in the development of robotic-assisted technology for cancer treatment. The company's primary product is the Epione® robotic platform, which is designed to facilitate more precise and less invasive treatments for inoperable tumors in the abdomen and lungs.

The company operates within the medical technology market, specifically focusing on interventional oncology. Its target clients are healthcare providers and physicians who treat patients with abdominal and lung cancers. With over 6 million new cases of these cancers diagnosed annually, Quantum Surgical aims to make its innovative treatment approach more accessible to a larger patient population.

The business model of Quantum Surgical revolves around the development, marketing, and sale of its Epione® robotic platform. The company generates revenue through the sale of these platforms to healthcare providers. The Epione® device has received CE marking for abdomen and lung indications and FDA clearance for abdominal ablation indication, which allows the company to market and sell the device in various markets.

Quantum Surgical's strategy is rooted in leveraging its extensive background in medical robotics to deliver innovative solutions in interventional oncology. The company aims to overcome current challenges in cancer treatment, expand physician capabilities, and standardize treatments. Ultimately, the goal is to transform medical intervention and provide access to cancer treatment in the least invasive manner possible.

Keywords: Quantum Surgical, Epione® Robotic Platform, Cancer Treatment, Interventional Oncology, Medical Robotics, Abdominal and Lung Cancers, Minimally Invasive Treatment, Healthcare Technology, FDA Clearance, CE Marking.